Cencora (WBO:ABC) Short-Term Debt: €109 Mil (As of Mar. 2026)


WBO:ABC Cencora Inc WBO:ABC
69 GF Score
Price €268.30
GF Value €257.70
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is Cencora Short-Term Debt?

Cencora WBO:ABC +3.99% 69 Short-Term Debt is €109 Mil as of Mar. 2026. GuruFocus rates WBO:ABC with a GF Score™ of 69/100 and a GF Value™ of €257.70 (Fairly Valued). The stock has 1 warning sign investors should review.

Cencora's Short-Term Debt for the quarter that ended in Mar. 2026 was €109 Mil.

Cencora's quarterly Short-Term Debt increased from Sep. 2025 (€100 Mil) to Dec. 2025 (€292 Mil) but then declined from Dec. 2025 (€292 Mil) to Mar. 2026 (€109 Mil).

Cencora's annual Short-Term Debt declined from Sep. 2023 (€601 Mil) to Sep. 2024 (€519 Mil) and declined from Sep. 2024 (€519 Mil) to Sep. 2025 (€100 Mil).

Cencora Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Cencora Short-Term Debt Related Terms

Cencora Short-Term Debt Historical Data

* Premium members only.

The historical data trend for Cencora's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cencora Short-Term Debt Chart

Cencora Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 255.18 1,081.18 600.94 519.27 100.35

Cencora Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 661.49 57.81 100.35 292.30 109.35
WBO:ABC
69GF Score
Cencora Inc WBO:ABC
Short-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of €109 Mil mean?
Cencora (WBO:ABC) has a Short-Term Debt of €109 Mil as of Mar. 2026.
Is Cencora's Short-Term Debt too high?
Cencora's current Short-Term Debt is €109 Mil. Overall, Cencora has a GF Score™ of 69/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Cencora's Short-Term Debt compare to CAH and MCK?
Cencora's Short-Term Debt of €109 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Medical Distribution company?
A good Short-Term Debt depends on the Medical Distribution industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. Cencora's current Short-Term Debt is €109 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cencora stock overvalued right now?
Based on GuruFocus' analysis, Cencora (WBO:ABC) is currently considered Fairly Valued. The stock's GF Value™ is €257.70, compared to a current price of €268.30 — trading 4.1% above its estimated fair value. The current Short-Term Debt is €109 Mil. Cencora's overall GF Score™ is 69/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For Cencora (WBO:ABC), the current Short-Term Debt is €109 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cencora (WBO:ABC) Overvalued in 2026?

Based on GuruFocus' analysis, Cencora stock appears to be overvalued. The current stock price of €268.30 is trading 4.1% above its estimated GF Value™ of €257.70. GuruFocus considers Cencora to be Fairly Valued.

Key valuation signals for WBO:ABC:

  • Short-Term Debt: €109 Mil
  • GF Value™: €257.70 vs. price of €268.30 (4.1% above fair value)
  • GF Score™: 69/100 with 1 warning sign

No single metric tells the full story. See the WBO:ABC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cencora Business Description

Address 1 West First Avenue, Conshohocken, PA, USA, 19428-1800
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
69GF Score

Get the complete analysis for WBO:ABC

Short-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€268.30
Price
€257.70
GF Value